A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor
- PMID: 8479521
- DOI: 10.1038/362839a0
A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor
Abstract
Extracellular deposition of amyloid beta-protein (beta-AP), or A4 protein (M(r) 4,000), is associated with Alzheimer's disease and with Down's syndrome (trisomy for chromosome 21). The large membrane-bound precursor protein (APP) of beta-AP is normally cleaved within the beta-AP region by a putative proteinase (APP secretase) to release its extracellular portion; beta-AP is produced by an alternative proteolytic processing. Here we demonstrate that APP contains a proteinase inhibitor domain for the matrix metalloproteinase gelatinase A, which is located in the C-terminal glycosylated region of the secretory forms of APP. In addition, we show that the gelatinase has an APP secretase-like activity, which hydrolyses the Lys16-Leu17 bond in the beta-AP sequence. Our results indicate that the proteinase inhibitor domain of APP and gelatinase A may be involved in the formation of beta-AP.
Comment in
-
Gelatinase A not alpha-secretase?Nature. 1994 Jan 6;367(6458):27-8. doi: 10.1038/367027a0. Nature. 1994. PMID: 7906388 No abstract available.
Similar articles
-
Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.Neurobiol Dis. 2005 Nov;20(2):625-37. doi: 10.1016/j.nbd.2005.05.004. Epub 2005 Jun 3. Neurobiol Dis. 2005. PMID: 15936948
-
Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.J Neurosci Res. 2003 Nov 1;74(3):386-92. doi: 10.1002/jnr.10745. J Neurosci Res. 2003. PMID: 14598315
-
Processing of the Alzheimer's disease amyloid precursor protein in Pichia pastoris: immunodetection of alpha-, beta-, and gamma-secretase products.Biochemistry. 1998 Oct 20;37(42):14958-65. doi: 10.1021/bi981063l. Biochemistry. 1998. PMID: 9778373
-
The amyloid peptide precursor in Alzheimer's disease.Acta Neurol Belg. 1995 Dec;95(4):197-209. Acta Neurol Belg. 1995. PMID: 8553793 Review.
-
[Strategies for identification of secretases implicated in Alzheimer's disease].Ann Biol Clin (Paris). 1998 May-Jun;56(3):277-84. Ann Biol Clin (Paris). 1998. PMID: 9754260 Review. French.
Cited by
-
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.Int J Mol Sci. 2021 Jan 30;22(3):1413. doi: 10.3390/ijms22031413. Int J Mol Sci. 2021. PMID: 33573368 Free PMC article. Review.
-
Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP.Front Aging Neurosci. 2019 Sep 24;11:244. doi: 10.3389/fnagi.2019.00244. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31607898 Free PMC article. Review.
-
Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.Cell Mol Life Sci. 2019 Aug;76(16):3167-3191. doi: 10.1007/s00018-019-03178-2. Epub 2019 Jun 13. Cell Mol Life Sci. 2019. PMID: 31197405 Free PMC article. Review.
-
Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders.Front Cell Neurosci. 2017 Jun 30;11:178. doi: 10.3389/fncel.2017.00178. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28713245 Free PMC article. Review.
-
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.Mediators Inflamm. 2015;2015:620581. doi: 10.1155/2015/620581. Epub 2015 Oct 11. Mediators Inflamm. 2015. PMID: 26538832 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
